Harrington Robert Arthur bought CYTK
January 2, 2024 · Form 4 insider transaction
Harrington Robert Arthur bought 148 shares of Cytokinetics, Incorporated at $84.12 per share, a transaction worth $12.4K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
148
Price
$84.12
Total value
$12.4K
InsiderHarrington Robert Arthur
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2024
Filing dateJanuary 3, 2024
Shares owned after11,521
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of director's annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $84.12, representing the closing stock price of the Issuer's common stock on January 2, 2024.